Sayson, Delia R.

HRN: 27-56-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2025
RIFAXIMIN 200MG (TAB)
09/23/2025
09/29/2025
ORAL
400mg
Three Times A Day
Rectal Mass Probably Malignant With Liver Mets
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines